@isthi
iAccount based inUnited States
About this account
- Account based in
- United States
- Connected via
- United States App Store
Account-level information from X, not a live location or the device used for a specific post.
The ISTH (nonprofit) offers a variety of educational programs & events for those who have a scientific interest in thrombosis, hemostasis & vascular biology.
Joined February 2009
- Tweets21.8K
- Following2.1K
- Followers15.4K
- Likes19.4K
What are the right ingredients for impactful science? For Jerrold Levy, they include curiosity, collaboration and bringing the right people and disciplines together. Get to know the incoming Chair of the ISTH SSC
🔗: isth.org/news/735267/The-rig…
New mechanisms require new conversations. Watch experts explain anti-TFPI therapies and how to communicate them clearly with patients in this free on-demand webinar: rebrand.ly/9482SM
Today is #WorldPatientSafetyDay. Safe, high-quality care is essential for everyone, especially for people living with NCDs who require ongoing treatment and long-term support.
ISTH retweeted
We’re exploring the evolving conversation around GLP-1 therapies and vascular health with @ISTH Pulse Podcast, including what we know and what we still need to learn about potential VTE risk.
GLP-1 receptor agonists are increasingly used in the treatment of type 2 diabetes and obesity, but what do we know about their potential relationship with venous thromboembolism (VTE)?
Tune in to a special episode of the ISTH Pulse Podcast: soundcloud.com/isth_thepulse…
ISTH retweeted
Replying to @isth
@isth - Closing the Global Gap in NCD Prevention and Care
hemostasistoday.com/voices/i…
#HemostasisToday
There’s still time to register for the upcoming ISTH webinar on gene editing in hemostasis, happening September 29.
Don’t miss the conversation: bit.ly/4qxgXCG
NEW: Tune in to this new RPTH Research Recap on how TIE2-positive endothelial cells appear early in thrombus resolution and why endomucin may be a useful marker of revascularizing endothelial cells: youtu.be/Mb4Zi5cINKo
ISTH retweeted
How do we translate the evidence into better thrombosis care? In this expert panel, leading voices in thrombosis explore the latest evidence around thrombophilia screening, clinical management and future directions in care.
▶️ Watch: youtube.com/watch?v=s9TDtnpj…
ISTH retweeted
Emerging science deserves more than just a lecture. Our latest collaboration with @isth combines expert faculty, real-world cases, and evolving clinical evidence to prepare neurologists for the potential future of stroke prevention.
rebrand.ly/9481CM
#StrokeCare
Join us TODAY at 15:30 UTC for the 2nd installment of our Ask Me Anything – Implementing Gene Therapy for Hemophilia series. Experts will discuss:
💡Emerging innovations in gene therapy
🌍The evolving European landscape
🔭Future directions for hemophilia care
Register: bit.ly/4A5gwnE
🏆 Nominations are now open for the ISTH Esteemed Career Awards! Members are invited to recognize colleagues whose careers have made an exceptional impact on the understanding and treatment of thrombosis and hemostasis.
Submit your nomination by Oct 9: isth.org/page/esteemednoms
In this episode of the ISTH Pulse Podcast, Dr. Deepa Arachchillage and Dr. Vicky Danilatou discuss what physicians and healthcare professionals should know about the legal and ethical implications of using AI in the clinic: soundcloud.com/isth_thepulse…
Our upcoming RPTH Research Recap features a deep dive into the recently published paper: Visualization of new vessel formation during venous thrombus organization using genetic fate mapping.
Stay tuned for the full conversation and read the paper: hwww.rpthjournal.org/article…
ISTH retweeted
Be sure to register for the 4th All-Russian Congress with International Participation, “Thrombosis Day in Russia – 2026,” held in recognition of #WorldThrombosisDay.
🔗 Learn more: thrombosisday.ru
ISTH retweeted
Suspected PE. The usual diagnostic pathway doesn’t quite fit. What now?
At this year’s Rapid Fire session, Grégoire Le Gal will tackle PE Diagnosis Challenges, one of five focused clinical questions designed to get quickly to the decisions that matter in practice.
Thrombosis Unpacked: Decisions That Matter
November 7 | Montréal
Explore the program:
buff.ly/x0Mh678
#PulmonaryEmbolism #Thrombosis #Anticoagulation #MedEd
Next week, on September 17, we recognize #WorldPatientSafetyDay. 🩺
With NCDs accounting for 74% of deaths worldwide, strengthening prevention, long-term management and access to safe care is a global priority. #PatientSafety #NCDs #GlobalHealth
Registration is open for the 4th All-Russian Congress with International Participation, “Thrombosis Day in Russia – 2026,” held in recognition of #WorldThrombosisDay.
🔗 Learn more: thrombosisday.ru/
How does thrombosis risk change across a woman’s life and where are the biggest gaps in care? In recognition of World Thrombosis Day, the Anticoagulation Forum will host a webinar examining thrombotic risk in women across the lifespan.
🔗Register: acforum.org/web/education-we…
ISTH retweeted
How are we improving the detection of Factor XIII deficiencies? Dr. Zsuzsanna Bagoly shares the updated diagnostic and classification recommendations from the ISTH 2026 Congress. Explore the new clinical standards below! 👇
@isth